This blend combines two well-documented synthetic peptides commonly referenced in preclinical and laboratory research exploring cellular signalling, tissue-related pathways, and peptide stability within controlled research systems
This is particularly relevant for injectable formulations obtained outside standard pharmaceutical channels, where risks of contamination, endotoxin exposure, or improper compounding may exceed any theoretical biologic effect
GlucoVantage (dihydroberberine, 5X more bioavailable than standard berberine) & berberine HCL, which both support healthy insulin sensitivity levels by activating AMPK and supporting glucose uptake and utilization in muscle cells
Circulation 140 , 16611678 (2019)
Progress in these areas will require not only rigorous experimental design but also close interdisciplinary collaboration between pharmacologists, formulation scientists, veterinary clinicians, and regulatory stakeholders to ensure translational relevance, safety, and real-world applicability